BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19593320)

  • 21. [Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].
    Gutman G; Geva E; Lessing JB; Amster R
    Harefuah; 2007 Nov; 146(11):889-93, 908. PubMed ID: 18087838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polycystic ovary syndrome (PCOS)].
    Torre A; Fernandez H
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36(5):423-46. PubMed ID: 17540511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
    Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
    Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovarian syndrome in adolescence.
    Yii MF; Lim CE; Luo X; Wong WS; Cheng NC; Zhan X
    Gynecol Endocrinol; 2009 Oct; 25(10):634-9. PubMed ID: 19533479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome: new perspective on an old problem.
    Slowey MJ
    South Med J; 2001 Feb; 94(2):190-6. PubMed ID: 11235033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and the polycystic ovary syndrome.
    Magnotti M; Futterweit W
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome and cardiovascular disease.
    Loverro G
    Minerva Endocrinol; 2004 Sep; 29(3):129-38. PubMed ID: 15282445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
    Jovanovic VP; Carmina E; Lobo RA
    Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
    Huang G; Coviello A
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovarian syndrome: is community care appropriate?
    Gupta S
    Int J Clin Pract; 1999; 53(5):359-62. PubMed ID: 10695100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome: clinical considerations.
    Marshall K
    Altern Med Rev; 2001 Jun; 6(3):272-92. PubMed ID: 11410072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.